Rapid recruitment and activation of macrophages by anti-gal/α-gal liposome interaction accelerates wound healing

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4422-4432

  Wigglesworth, Kim M ^a   Racki, Waldemar J ^a   Mishra, Rabinarayan ^a   Szomolanyi Tsuda, Eva ^a   Greiner, Dale L ^a   Galili, Uri ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; ANTIBODY; EPITOPE; FC RECEPTOR; GAL ANTIBODY; GALALPHA1-3GALBETA1-4GLCNAC R EPITOPE; LIPOSOME; NANOPARTICLE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EPIDERMIS; FEMALE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR BINDING; SCAR FORMATION; SKIN INJURY; WILD TYPE; WOUND HEALING;

ANIMALS; BINDING SITES, ANTIBODY; CELL MOVEMENT; COMPLEMENT ACTIVATION; EPITOPES; GALACTOSYLTRANSFERASES; GLYCOLIPIDS; LIPOSOMES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; RABBITS; SWINE; TRISACCHARIDES; WOUND HEALING;

EID: 79954998873     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002324     Document Type: Article

References (57)

1. Leibovich, S. J., and R. Ross. 1975. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am. J. Pathol. 78: 71-100.
2. DiPietro, L. A. 1995. Wound healing: The role of the macrophage and other immune cells. Shock 4: 233-240.
3. Singer, A. J., and R. A. Clark. 1999. Cutaneous wound healing. N. Engl. J. Med. 341: 738-746. (Pubitemid 29407375)
4. Martin, P. 1997. Wound healing-aiming for perfect skin regeneration. Science 276: 75-81. (Pubitemid 27161246)
5. Duffield, J. S., S. J. Forbes, C. M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang, and J. P. Iredale. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115: 56-65. (Pubitemid 40385505)
6. Daley, J. M., S. K. Brancato, A. A. Thomay, J. S. Reichner, and J. E. Albina. 2010. The phenotype of murine wound macrophages. J. Leukoc. Biol. 87: 59-67.
7. Danon, D., J. Madjar, E. Edinov, A. Knyszynski, S. Brill, L. Diamantshtein, and E. Shinar. 1997. Treatment of human ulcers by application of macrophages prepared from a blood unit. Exp. Gerontol. 32: 633-641. (Pubitemid 27518245)
8. Piccolo, M. T., Y. Wang, P. Sannomiya, N. S. Piccolo, M. S. Piccolo, T. E. Hugli, P. A. Ward, and G. O. Till. 1999. Chemotactic mediator requirements in lung injury following skin burns in rats. Exp. Mol. Pathol. 66: 220-226. (Pubitemid 29445049)
9. Heinrich, S. A., K. A. Messingham, M. S. Gregory, A. Colantoni, A. M. Ferreira, L. A. Dipietro, and E. J. Kovacs. 2003. Elevated monocyte chemoattractant protein-1 levels following thermal injury precede monocyte recruitment to the wound site and are controlled, in part, by tumor necrosis factor-alpha. Wound Repair Regen. 11: 110-119. (Pubitemid 36514822)
10. Shukaliak, J. A., and K. Dorovini-Zis. 2000. Expression of the beta-chemokines RANTES and MIP-1 beta by human brain microvessel endothelial cells in primary culture. J. Neuropathol. Exp. Neurol. 59: 339-352. (Pubitemid 30257563)
11. Franz, M. G., D. L. Steed, and M. C. Robson. 2007. Optimizing healing of the acute wound by minimizing complications. Curr. Probl. Surg. 44: 691-763. (Pubitemid 350129811)
12. Shallo, H., T. P. Plackett, S. A. Heinrich, and E. J. Kovacs. 2003. Monocyte chemoattractant protein-1 (MCP-1) and macrophage infiltration into the skin after burn injury in aged mice. Burns 29: 641-647. (Pubitemid 37230078)
13. Snyderman, R., and M. C. Pike. 1984. Chemoattractant receptors on phagocytic cells. Annu. Rev. Immunol. 2: 257-281.
14. Haeney, M. R. 1998. The role of the complement cascade in sepsis. J. Antimicrob. Chemother. 41(Suppl. A): 41-46. (Pubitemid 28062143)
15. Galili, U., E. A. Rachmilewitz, A. Peleg, and I. Flechner. 1984. A unique natural human IgG antibody with anti-α-galactosyl specificity. J. Exp. Med. 160: 1519-1531. (Pubitemid 15220780)
16. Wang, L., F. Anaraki, T. R. Henion, and U. Galili. 1995. Variations in activity of the human natural anti-Gal antibody in young and elderly populations. J. Gerontol. A Biol. Sci. Med. Sci. 50: M227-M233.
17. Galili, U., R. E. Mandrell, R. M. Hamadeh, S. B. Shohet, and J. M. Griffiss. 1988. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun. 56: 1730-1737.
18. Galili, U., B. A. Macher, J. Buehler, and S. B. Shohet. 1985. Human natural antia- galactosyl IgG. II. The specific recognition of a (1-3)-linked galactose residues. J. Exp. Med. 162: 573-582. (Pubitemid 15249960)
19. Galili, U., M. R. Clark, S. B. Shohet, J. Buehler, and B. A. Macher. 1987. Evolutionary relationship between the natural anti-Gal antibody and the Gala1- 3Gal epitope in primates. Proc. Natl. Acad. Sci. USA 84: 1369-1373. (Pubitemid 17027355)
20. Galili, U., S. B. Shohet, E. Kobrin, C. L. M. Stults, and B. A. Macher. 1988. Man, apes, and Old World monkeys differ from other mammals in the expression of a-galactosyl epitopes on nucleated cells. J. Biol. Chem. 263: 17755-17762.
21. Galili, U. 1993. Interaction of the natural anti-Gal antibody with a-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol. Today 14: 480-482. (Pubitemid 23300997)
22. Good, H., D. K. C. Cooper, A. J. K. Malcolm, R. M. Ippolito, E. Koren, F. A. Neethling, Y. Ye, N. Zuhdi, and L. R. Lamontagne. 1992. Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting grafting in man. Transplant. Proc. 24: 559-562.
23. Sandrin, M. S., H. A. Vaughan, P. L. Dabkowski, and I. F. C. McKenzie. 1993. Anti-pig IgM antibodies in human serum react predominantly with Gal(a1-3)Gal epitopes. Proc. Natl. Acad. Sci. USA 90: 11391-11395. (Pubitemid 23354435)
24. Collins, B. H., A. H. Cotterell, K. R. McCurry, C. G. Alvarado, J. C. Magee, W. Parker, and J. L. Platt. 1995. Cardiac xenografts between primate species provide evidence for the importance of the a-galactosyl determinant in hyperacute rejection. J. Immunol. 154: 5500-5510.
25. Sachs, D. H., M. Sykes, S. C. Robson, and D. K. Cooper. 2001. Xenotransplantation. Adv. Immunol. 79: 129-223. (Pubitemid 32977576)
26. Ravetch, J. V., and S. Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19: 275-290. (Pubitemid 32368037)
27. Thall, A. D., P. Malý, and J. B. Lowe. 1995. Oocyte Gala1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 270: 21437-21440.
28. Tanemura, M., D. Yin, A. S. Chong, and U. Galili. 2000. Differential immune responses to a-gal epitopes on xenografts and allografts: Implications for accommodation in xenotransplantation. J. Clin. Invest. 105: 301-310. (Pubitemid 30094450)
29. Abdel-Motal, U., S. Wang, S. Lu, K. Wigglesworth, and U. Galili. 2006. Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Gala1-3Galb1-4GlcNAc-R epitopes. J. Virol. 80: 6943-6951. (Pubitemid 44025193)
30. Abdel-Motal, U. M., K. Wigglesworth, and U. Galili. 2009. Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody. Vaccine 27: 3072-3082.
31. LaTemple, D. C., J. T. Abrams, S. Y. Zhang, and U. Galili. 1999. Increased immunogenicity of tumor vaccines complexed with anti-Gal: Studies in knockout mice for a1,3galactosyltransferase. Cancer Res. 59: 3417-3423. (Pubitemid 29334502)
32. Manches, O., J. Plumas, G. Lui, L. Chaperot, J. P. Molens, J. J. Sotto, J. C. Bensa, and U. Galili. 2005. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: A potential method for immunotherapy using autologous tumor cells. Haematologica 90: 625-634. (Pubitemid 40780881)
33. Galili, U., K. Wigglesworth, and U. M. Abdel-Motal. 2007. Intratumoral injection of a-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines. J. Immunol. 178: 4676-4687. (Pubitemid 46501667)
34. Eto, T., Y. Ichikawa, K. Nishimura, S. Ando, and T. Yamakawa. 1968. Chemistry of lipid of the posthemyolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes of rabbit. J. Biochem. 64: 205-213.
35. Stellner, K., H. Saito, and S. Hakomori. 1973. Determination of aminosugar linkage in glycolipids by methylation. Aminosugar linkage of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen. Arch. Biochem. Biophys. 155: 464-472.
36. Dabrowski, U., P. Hanfland, H. Egge, S. Kuhn, and J. Dabrowski. 1984. Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Determination of branching patterns of a ceramide pentadecasaccharide by 1H nuclear magnetic resonance. J. Biol. Chem. 259: 7648-7651. (Pubitemid 14081174)
37. Egge, H., M. Kordowicz, J. Peter-Katalinić, and P. Hanfland. 1985. Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Characterization of linear, di-, and triantennary neolactoglycosphingolipids. J. Biol. Chem. 260: 4927-4935. (Pubitemid 15038688)
38. Hanfland, P., M. Kordowicz, J. Peter-Katalinić, H. Egge, J. Dabrowski, and U. Dabrowski. 1988. Structure elucidation of blood group B-like and I-active ceramide eicosa- and pentacosasaccharides from rabbit erythrocyte membranes by combined gas chromatography-mass spectrometry; electron-impact and fastatom- bombardment mass spectrometry; and two-dimensional correlated, relayed-coherence transfer, and nuclear Overhauser effect 500-MHz 1H-n.m.r. spectroscopy. Carbohydr. Res. 178: 1-21.
39. Honma, K., H. Manabe, M. Tomita, and A. Hamada. 1981. Isolation and partial structural characterization of macroglycolipid from rabbit erythrocyte membranes. J. Biochem. 90: 1187-1196. (Pubitemid 12174824)
40. Galili, U., K. Wigglesworth, and U. M. Abdel-Motal. 2010. Accelerated healing of skin burns by anti-Gal/a-gal liposomes interaction. Burns 36: 239-251.
41. Byrne, G. W., P. G. Stalboerger, E. Davila, C. J. Heppelmann, M. H. Gazi, H. C. McGregor, P. T. LaBreche, W. R. Davies, V. P. Rao, K. Oi, et al. 2008. Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation. Xenotransplantation 15: 268-276.
42. Galili, U. 2005. The a-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol. Cell Biol. 83: 674-686. (Pubitemid 43083100)
43. Hamadeh, R. M., U. Galili, P. Zhou, and J. M. Griffis. 1995. Anti-α-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions. Clin. Diagn. Lab. Immunol. 2: 125-131.
44. Parker, W., D. Bruno, Z. E. Holzknecht, and J. L. Platt. 1994. Characterization and affinity isolation of xenoreactive human natural antibodies. J. Immunol. 153: 3791-3803. (Pubitemid 24313885)
45. Vorauer-Uhl, K., E. Fürnschlief, A. Wagner, B. Ferko, and H. Katinger. 2002. Reepithelialization of experimental scalds effected by topically applied superoxide dismutase: Controlled animal studies. Wound Repair Regen. 10: 366-371. (Pubitemid 36025335)
46. Plock, J. A., N. Rafatmehr, D. Sinovcic, J. Schnider, H. Sakai, E. Tsuchida, A. Banic, and D. Erni. 2009. Hemoglobin vesicles improve wound healing and tissue survival in critically ischemic skin in mice. Am. J. Physiol. Heart Circ. Physiol. 297: H905-H910.
47. Jeschke, M. G., and D. N. Herndon. 2007. The combination of IGF-I and KGF cDNA improves dermal and epidermal regeneration by increased VEGF expression and neovascularization. Gene Ther. 14: 1235-1242. (Pubitemid 47215425)
48. Roy, S., S. Khanna, C. Rink, S. Biswas, and C. K. Sen. 2008. Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol. Genomics 34: 162-184.
49. Kelley, J. L., C. A. Suenram, M. M. Rozek, and C. J. Schwartz. 1988. Influence of hypercholesterolemia and cholesterol accumulation on rabbit carrageenan granuloma macrophage activation. Am. J. Pathol. 131: 539-546.
50. Aguiar-Passeti, T., E. Postol, C. Sorg, and M. Mariano. 1997. Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation. J. Leukoc. Biol. 62: 852-858. (Pubitemid 28015634)
51. Galili, U. 2004. Immune response, accommodation, and tolerance to transplantation carbohydrate antigens. Transplantation 78: 1093-1098. (Pubitemid 39426422)
52. Sen, C. K., G. M. Gordillo, S. Roy, R. Kirsner, L. Lambert, T. K. Hunt, F. Gottrup, G. C. Gurtner, and M. T. Longaker. 2009. Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair Regen. 17: 763-771.
53. Orenstein, A., E. Kachel, A. Zuloff-Shani, Y. Paz, O. Sarig, J. Haik, A. K. Smolinsky, R. Mohr, E. Shinar, and D. Danon. 2005. Treatment of deep sternal wound infections post-open heart surgery by application of activated macrophage suspension. Wound Repair Regen. 13: 237-242. (Pubitemid 40848015)
54. Galili, U., A. Tibell, B. Samuelsson, L. Rydberg, and C. G. Groth. 1995. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 59: 1549-1556.
55. Baumann, B. C., G. Stussi, K. Huggel, R. Rieben, and J. D. Seebach. 2007. Reactivity of human natural antibodies to endothelial cells from Gala(1,3)Galdeficient pigs. Transplantation 83: 193-201. (Pubitemid 46185210)
56. Galili, U., H. Ishida, K. Tanabe, and H. Toma. 2002. Anti-Gal A/B, a novel antiblood group antibody identified in recipients of ABO-incompatible kidney allografts. Transplantation 74: 1574-1580. (Pubitemid 36014231)
57. Crainic, K., M. Durigon, and R. Oriol. 1989. ABO tissue antigens of Egyptian mummies. Forensic Sci. Int. 43: 113-124. (Pubitemid 19275361)